LOGIN
Corticosteroid-Enhanced Hydrodilatation for Adhesive Capsulitis
October 2025
Corticosteroid-Enhanced Hydrodilatation for Adhesive Capsulitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A prospective, randomized, blinded study on the efficacy of using corticosteroids in hydrodilatation as a treatment for adhesive capsulitis of the shoulder.
Shoulder Elbow . 2025 Jul;17(3):274-281.Synopsis
Eighty-two patients with primary adhesive capsulitis were randomized to hydrodilatation with corticosteroid (HDC; betamethasone 11.4 mg + lidocaine 2% + saline, total 20 mL; n=41) or hydrodilatation without corticosteroid (HDA; lidocaine 2% + saline, total 20 mL; n=41). The primary outcome was SPADI. Secondary outcomes included VAS pain, SST, and 12-month SSV. Outcomes were assessed at 48 hours (p...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.